Drug Enforcement D-0633-2024

Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

Status

Completed

Classification

Class III

Report Date

August 21, 2024

Termination Date

Product Information

Product description
Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-3007-01
Product quantity
96 vials
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Product was distributed to one distributor

Location & Firm

Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
Address
3 Skyline Dr

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0633-2024
Event ID
95125
Recall initiation date
August 7, 2024
Center classification date
August 13, 2024
Code info
Lot # AD12890, Exp 09/30/2024
More code info